Adaptive Biotechnologies ADPT Enterprise value

Enterprise value at other companies

Biodesix, Inc.BDSX

$275.32M+200%

Guardant HealthGH

$12.72B+121%

Natera, Inc.NTRA

$38.02B+67.8%

GeneDx HoldingsWGS

$1.88B-22.8%

Personalis, Inc.PSNL

$631.91M+125%

Myriad GeneticsMYGN

$506.29M-41.6%

FAQ

What is Adaptive Biotechnologies's enterprise value?

Adaptive Biotechnologies (ADPT) reported enterprise value of $2.27B in Q1 2026.

How has Adaptive Biotechnologies's enterprise value changed year-over-year?

Adaptive Biotechnologies's enterprise value increased by 78.0% year-over-year, from $1.27B to $2.27B.

What is the long-term trend for Adaptive Biotechnologies's enterprise value?

Over 5 years (2020 to 2025), Adaptive Biotechnologies's enterprise value has grown at a -20.7% compound annual growth rate (CAGR), from $8.33B to $2.62B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.